<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="11422">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01686906</url>
  </required_header>
  <id_info>
    <org_study_id>NIIOS-BL-2012</org_study_id>
    <nct_id>NCT01686906</nct_id>
  </id_info>
  <brief_title>Isolated Bowman Layer Graft for Reducing and Stabilizing Advanced Keratoconus</brief_title>
  <official_title>Mid-stromal Isolated Bowman Layer Graft Implantation to Reduce and Stabilize Advanced Keratoconus</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Netherlands Institute for Innovative Ocular Surgery</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Amnitrans Eyebank Rotterdam</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Netherlands Institute for Innovative Ocular Surgery</source>
  <oversight_info>
    <authority>The Netherlands: Independent Ethics Committee</authority>
  </oversight_info>
  <brief_summary>
    <textblock>
      To evaluate the efficacy of mid-stromal implantation of an isolated Bowman layer graft, to
      reduce and stabilize ectasia in eyes with advanced keratoconus
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>January 2011</start_date>
  <completion_date type="Anticipated">December 2020</completion_date>
  <primary_completion_date type="Anticipated">December 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <study_design>Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment</study_design>
  <primary_outcome>
    <measure>Corneal power</measure>
    <time_frame>2011-2020</time_frame>
    <safety_issue>No</safety_issue>
    <description>Reduction and stabilizing of the corneal power after Bowman layer graft implantation</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Best corrected visual acuity</measure>
    <time_frame>2011-2020</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">100</enrollment>
  <condition>Advanced Keratoconus</condition>
  <arm_group>
    <arm_group_label>Bowman layer graft implantation</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Bowman layer graft implantation</intervention_name>
    <description>For patients with progressive advanced keratoconus, a mid-stromal manual dissection is made and a donor isolated Bowman layer is positioned into the stromal pocket.</description>
    <arm_group_label>Bowman layer graft implantation</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

        â€¢Advanced keratoconus

        Exclusion Criteria:

          -  Further ophthalmic diseases

          -  History of ocular surgery

          -  Pregnancy, brest feeding
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>16 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Gerrit RJ Melles, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Netherlands Institute for Innovative Ocular Surgery</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Netherlands Institute for Innovative Ocular Surgery</name>
      <address>
        <city>Rotterdam</city>
        <zip>3071 AA</zip>
        <country>Netherlands</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Kim Herders, MSc</last_name>
      <phone>+31-10-297</phone>
      <phone_ext>4444</phone_ext>
      <email>herders@niios.com</email>
    </contact>
    <investigator>
      <last_name>Gerrit RJ Melles, MD, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Netherlands</country>
  </location_countries>
  <verification_date>September 2012</verification_date>
  <lastchanged_date>September 13, 2012</lastchanged_date>
  <firstreceived_date>September 13, 2012</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Keratoconus</keyword>
  <keyword>Bowman layer</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Keratoconus</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
